Pharmacy Times August 11, 2024
Catherine A. Koivisto, RPh

The use of CGMs in pregnancy provides clinicians with essential data in real-time, rather than a snapshot given by traditional finger stick testing.

Patients with diabetes face extra challenges when pregnant because glycemic control is essential for a healthy pregnancy and reducing risks of fetal malformations. Diabetes during pregnancy significantly increases the risk of preeclampsia and elevated maternal risks also include spontaneous abortion and infection.1

The importance of glucose monitoring for this population cannot be overemphasized. The use of continuous glucose monitors (CGMs) for diabetes management in pregnancy provides clinicians with essential data in real-time, rather than a snapshot given by traditional finger stick testing.1

Multiple CGMs are available on the market today, although most are available by prescription only....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article